SCHEMBL8985201

SCHEMBL8985201

CCOC(=O)CCCn1cnc(C)c1C=O

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TNF P01375 18/20 0.52
AMPD2 Q01433 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8985435 0.81 TNF (0.52) TNFAMPD2
SCHEMBL18366023 0.81 TNF (0.57) TNFAMPD2
SCHEMBL22887555 0.77 TNF (0.53) TNFAMPD2
SCHEMBL18366022 0.76 TNF (0.53) TNFAMPD2
SCHEMBL5654147 0.76 TNF (0.46) TNF
SCHEMBL17537381 0.74 TNF (0.66) TNF
SCHEMBL21131550 0.73 TNF (0.57) TNFAMPD2
SCHEMBL18366013 0.72 TNF (0.51) TNF
SCHEMBL5884818 0.72 TDP1 (0.61) TNF
SCHEMBL18366017 0.71 ALDH1A1 (0.58) TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5547961-A USING TETRAHYDROIMIDAZOPYRIDINE YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1996-08-20 US disclosed
US-5336679-A Treatment of irritable bowel syndrome YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-08-09 US disclosed
EP-0532754-A1 TETRAHYDROIMIDAZOPYRIDINE DERIVATIVE OR ITS SALT YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1993-03-24 EP disclosed